NIKI
Niki BioSolutions Inc.
NIKI | NASDAQ
$1.77
-$0.19 (-9.51%)
At close: Oct 30, 2026, 4:00 PM ET
$1.70
-$0.07 (-3.95%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 | Q4 2020 Dec 31, 2020 | Q2 2020 Jun 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 431.38K | 768.43K | 527.46K | 903.99K | 637.78K | 584.24K | 327.27K |
Cost of Revenue | n/a | n/a | n/a | n/a | 255.05K | 454.61K | 1.1M | 1.31M | 1.11M | 1.43M | 1.23M | 1.21M | 1.14M |
Gross Profit | n/a | n/a | n/a | n/a | -255K | -455K | -665K | -542K | -585K | -522K | -589K | -627K | -812K |
Operating Income | n/a | n/a | -402.77K | n/a | -2.87M | -3.99M | -6.54M | -9.06M | -8.45M | -9.71M | -9.49M | -11.61M | -8.29M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 149.73K | n/a | n/a | n/a | n/a |
Pretax Income | -310.54K | -616.6K | -449.3K | -770.35K | -2.66M | 2.26M | -6.61M | -8.8M | -2.73M | -10.01M | -17.1M | 11.91M | -6.99M |
Net Income | -307.5K | -614K | -441.78K | -919.9K | -2.64M | 2.66M | -5.49M | -7.91M | -1.89M | -8.97M | -16.08M | 13.27M | -6.21M |
Selling & General & Admin | 617.2K | 411.9K | 606.3K | 445.33K | 688.87K | 1.46M | 2.95M | 4.3M | 3.67M | 4.11M | 3.69M | 3.96M | 3.4M |
Research & Development | 91.71K | 241.79K | 19.38K | -284.47K | 1.79M | 2.61M | 2.59M | 4.14M | 4.01M | 4.88M | 5.03M | 6.77M | 3.83M |
Other Expenses | 116.22K | -64.07K | -222.91K | -719.46K | -6.87K | -534K | 330K | 77.93K | 183K | 203K | 189K | 248K | 248K |
Operating Expenses | 825.13K | 589.63K | 402.77K | -558.6K | 2.47M | 3.54M | 5.87M | 8.52M | 7.87M | 9.19M | 8.91M | 10.98M | 7.48M |
Interest Expense | n/a | 26.96K | 46.53K | n/a | 68.46K | 27.67K | 93.48K | 3.15K | n/a | -3.7B | 126.1K | -3.7B | 1.58M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.99M | n/a | -2.26M | n/a | -2.73M | 641.46K |
Cost & Expenses | 825.13K | 589.63K | 402.77K | -558.6K | 2.87M | 3.99M | 6.97M | 9.83M | 8.98M | 10.62M | 10.13M | 12.19M | 8.62M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 73.52K | 72.39K | 71.27K | 62.9K | 53.4K | 51.82K | 38.5K | 35.71K | 35.68K | 35.64K | 34.28K | 34.02K | 29.96K |
Shares Outstanding (Diluted) | 73.52K | 72.39K | 71.27K | 62.9K | 53.4K | 51.82K | 38.5K | 35.71K | 35.68K | 35.64K | 34.28K | 34.02K | 29.96K |
EPS (Basic) | -4.20 | -8.50 | -6.20 | -14.60 | -49.50 | 51 | -142.50 | -221.60 | -52.80 | -251.60 | -469.10 | 390 | -207.10 |
EPS (Diluted) | -4.20 | -8.50 | -6.20 | -14.60 | -49.50 | 51 | -142.50 | -221.60 | -52.80 | -251.60 | -469.10 | 390 | -207.10 |
EBITDA | -825.13K | -589.63K | -402.77K | 275.92K | -2.34M | 2.74M | -5.84M | -8.17M | -2.15M | -9.42M | -16.38M | 12.64M | -6.14M |
EBIT | -825.13K | -589.63K | -402.77K | 275.92K | -2.59M | 2.29M | -6.51M | -8.79M | -2.73M | -10.01M | -16.98M | 12.01M | -6.84M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | 255.05K | 454.61K | 670.65K | 624.8K | 582.71K | 595.71K | 596.86K | 632.03K | 702.63K |
Add to Watchlist
Select watchlists to add or remove NIKI